11 September 1987
10 June 1986
COMMERCIAL ITEM DESCRIPTION
PENICILLIN G BENZATHINE SUSPENSION, STERILE, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Penicillin G Benzathine Suspension, Sterile, USP.
All ingredients shall be of pharmaceutical grade.
Shall be intramuscular use.
Shall contain 600,000 units of Penicillin G Benzathine per ml within the applicable assay limits for the suspension.
The suspension must be considered by the FDA to be therapeutically equivalent to Penicillin G Benzathine Suspension, Sterile, USP, by Wyeth Laboratories at the same dosage and administration schedule.
Workmanship. The Suspensions shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Package (PG).
For Strength 1, shall be supplied 1 ml in a 1 ml commercially available cartridge-needle unit (20 gage x 1-1/4 inch needle). One package containing 10 cartridge-needle units, as specified, constitutes one unit.
For Strength 2, shall be supplied 2 ml in a 2 ml commercially available cartridge-needle unit (20 gage x 1-1/4 inch needle). One package containing 10 cartridge-needle units, as specified, constitutes one unit.
The cartridge-needle units shall be compatible with 6515-00-926-9043 syringe-cartridge.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business